F H Stewart

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence
    F H Stewart
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 3333 California St, Suite 335, San Francisco, CA 94143 0744, USA
    JAMA 285:2232-9. 2001
  2. ncbi Abortion: teaching why as well as how
    Felicia H Stewart
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
    Perspect Sex Reprod Health 35:37-9. 2003
  3. ncbi Knowledge of emergency contraception among women aged 18 to 44 in California
    Diana G Foster
    Center for Reproductive Health Research and Policy, University of California, San Francisco 94143 1744, USA
    Am J Obstet Gynecol 191:150-6. 2004
  4. ncbi A prescription for real security
    Felicia H Stewart
    Contraception 70:179-81. 2004
  5. ncbi Care for women choosing medication abortion
    Diana Taylor
    Department of Family Health Care Nursing, University of California, San Francisco, USA
    Nurse Pract 29:65-70. 2004
  6. ncbi Willing and able? Provision of medication for abortion by future internists
    Eleanor Bimla Schwarz
    Department of Medicine, General Internal Medicine Section 111A1, University of California San Francisco, VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
    Womens Health Issues 15:39-44. 2005
  7. ncbi A qualitative study of insurers' coverage for mifepristone-induced abortion
    Marcel P Gemperli
    SCF, San Francisco, California 94143 1744, USA
    Manag Care Interface 18:26-30, 32. 2005
  8. ncbi Safety of mifepristone abortions in clinical use
    Jillian T Henderson
    Center for Reproductive Health Research and Policy, University of California, San Francisco, CA 94143, USA
    Contraception 72:175-8. 2005
  9. ncbi Cervical cancer screening continues to limit provision of contraception
    Eleanor Bimla Schwarz
    General Internal Medicine Section, Department of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94121, USA
    Contraception 72:179-81. 2005
  10. ncbi Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling
    Lee P Shulman
    Department of Obstetrics and Gynecology, Division of Reproductive Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Contraception 73:440-2. 2006

Collaborators

Detail Information

Publications25

  1. ncbi Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence
    F H Stewart
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 3333 California St, Suite 335, San Francisco, CA 94143 0744, USA
    JAMA 285:2232-9. 2001
    ....
  2. ncbi Abortion: teaching why as well as how
    Felicia H Stewart
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
    Perspect Sex Reprod Health 35:37-9. 2003
  3. ncbi Knowledge of emergency contraception among women aged 18 to 44 in California
    Diana G Foster
    Center for Reproductive Health Research and Policy, University of California, San Francisco 94143 1744, USA
    Am J Obstet Gynecol 191:150-6. 2004
    ..By using data from the 1999-2001 California Women's Health Survey, we estimated the knowledge of emergency contraception among adult women of reproductive age at risk of pregnancy (n=6209)...
  4. ncbi A prescription for real security
    Felicia H Stewart
    Contraception 70:179-81. 2004
  5. ncbi Care for women choosing medication abortion
    Diana Taylor
    Department of Family Health Care Nursing, University of California, San Francisco, USA
    Nurse Pract 29:65-70. 2004
  6. ncbi Willing and able? Provision of medication for abortion by future internists
    Eleanor Bimla Schwarz
    Department of Medicine, General Internal Medicine Section 111A1, University of California San Francisco, VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
    Womens Health Issues 15:39-44. 2005
    ..The development of medications such as mifepristone (RU486) has created the opportunity to introduce medication abortion as a component of office practice...
  7. ncbi A qualitative study of insurers' coverage for mifepristone-induced abortion
    Marcel P Gemperli
    SCF, San Francisco, California 94143 1744, USA
    Manag Care Interface 18:26-30, 32. 2005
    ..A model coverage policy that contains comprehensive clinical information regarding appropriate clinical regimens for mifepristone is provided as an example for insurers and others in the field...
  8. ncbi Safety of mifepristone abortions in clinical use
    Jillian T Henderson
    Center for Reproductive Health Research and Policy, University of California, San Francisco, CA 94143, USA
    Contraception 72:175-8. 2005
    ..Extensive data from clinical trials document mifepristone's safety and efficacy for induced abortion, but less information is available about its safety in routine clinical use...
  9. ncbi Cervical cancer screening continues to limit provision of contraception
    Eleanor Bimla Schwarz
    General Internal Medicine Section, Department of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94121, USA
    Contraception 72:179-81. 2005
    ..We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills...
  10. ncbi Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling
    Lee P Shulman
    Department of Obstetrics and Gynecology, Division of Reproductive Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Contraception 73:440-2. 2006
  11. ncbi Expanded state-funded family planning services: estimating pregnancies averted by the Family PACT Program in California, 1997-1998
    Diana Greene Foster
    University of California, San Francisco, 2356 Sutter St, Suite 200, UCSF Box 1744, San Francisco, CA 94143 1744, USA
    Am J Public Health 94:1341-6. 2004
    ..We estimated the impact on fertility of providing 500 000 women with contraceptives...
  12. ncbi Beyond access: acceptability, use and nonuse of emergency contraception among young women
    Corinne H Rocca
    Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Reproductive Health Research and Policy, School of Medicine, University of California, San Francisco, CA 94105, USA
    Am J Obstet Gynecol 196:29.e1-6; discussion 90.e1-5. 2007
    ..This study was undertaken to assess the acceptability of levonorgestrel emergency contraception (EC)...
  13. ncbi Title X: a sure-fire investment with at least a 300% return
    Felicia H Stewart
    Contraception 68:1. 2003
  14. ncbi Re: Advance supply of emergency contraception
    James Trussell
    J Pediatr Adolesc Gynecol 19:251. 2006
  15. ncbi ARHP editorial
    Felicia H Stewart
    Contraception 67:341. 2003
  16. ncbi Keeping abortion legal: a look beyond Roe v. Wade
    Felicia H Stewart
    Contraception 68:307-8. 2003
  17. ncbi Family planning in the balance
    Ann C Hwang
    Center for Reproductive Health Research and Policy, University of California, San Francisco, 94143, USA
    Am J Public Health 94:15-8. 2004
    ..In promoting an ideologically driven approach to sexual and reproductive health, the recent policy developments threaten to subvert ethical standards of medical care and the principle of evidence-based policy...
  18. ncbi A new year's resolution for reproductive health care
    Felicia H Stewart
    Contraception 69:1-2. 2004
  19. ncbi Making research matter
    Felicia H Stewart
    Contraception 69:87. 2004
  20. ncbi Ten priorities for women's health
    Ann C Hwang
    Contraception 70:265-8. 2004
  21. ncbi Presenting health risks honestly: mifepristone, a case in point
    Felicia H Stewart
    Contraception 69:177-8. 2004
  22. ncbi Family planning care: more than contraception
    Felicia H Stewart
    Contraception 69:261-2. 2004
  23. ncbi The 2005 United States budget: wasteful expenditures, foregone opportunities
    Felicia H Stewart
    Contraception 70:87-8. 2004
  24. ncbi The federal abortion ban: a clinical and moral dilemma, and international policy setback
    Felicia H Stewart
    Contraception 69:433-5. 2004
  25. ncbi Cairo goals for reproductive health: where do we stand at 10 years?
    Felicia H Stewart
    Contraception 70:1-2. 2004